- CUE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
DEFA14A Filing
Cue Biopharma (CUE) DEFA14AAdditional proxy soliciting materials
Filed: 29 May 18, 12:00am
SCHEDULE 14A
(Rule14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement ☐ Soliciting Material Under Rules14a-12 |
☐ | Confidential, For Use of the |
Commission Only (as permitted
by Rule14a-6(e)(2))
☐ | Definitive Proxy Statement |
☒ | Definitive Additional Materials |
Cue Biopharma, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required. |
☐ | Fee computed on table below per Exchange Act Rules14a-6(i)(4) and0-11. |
1) | Title of each class of securities to which transaction applies: |
2) | Aggregate number of securities to which transaction applies: |
3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
4) | Proposed maximum aggregate value of transaction: |
5) | Total fee paid: |
☐ | Fee paid previously with preliminary materials: |
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing. |
1) | Amount previously paid: |
2) | Form, Schedule or Registration Statement No.: |
3) | Filing Party: |
4) | Date Filed: |
CUE BIOPHARMA, INC.
Notice of Change of Location and Time of
Annual Meeting of Stockholders
June 12, 2018
May 25, 2018
To the Stockholders of Cue Biopharma, Inc.:
Cue Biopharma, Inc. has changed the location of its annual meeting of stockholders scheduled for Tuesday, June 12, 2018 (the “2018 Annual Meeting”). The meeting date, time and record date remain unchanged.
The new location for the 2018 Annual Meeting will be:
The Warwick Melrose Hotel
Oak Lawn Terrace Conference Room
3015 Oak Lawn Ave
Dallas, Texas 75219
The time of the 2018 Annual Meeting will be 9:00 a.m., local time.
A revised proxy card, reflecting the change in the location of the meeting, has been made available. If you have already voted and do not wish to change your vote, you do not need to do anything. Stockholders may also continue to use the form of proxy previously provided.
Admission to the 2018 Annual Meeting is limited to stockholders as of the close of business on April 23, 2018, holders of valid proxies for the 2018 Annual Meeting and our invited guests. Each stockholder may be asked to present valid picture identification, such as a driver’s license or passport, and proof of stock ownership as of the record date.
If you plan to attend the annual meeting and you require directions, please call us at(617) 949-2680.
Sincerely,
/s/ Colin Sandercock
Colin Sandercock
Senior Vice President, General Counsel and Secretary